Latest Huntington's disease Stories
Novel ZFP Therapeutic Approach Selectively Represses Expression of Huntington's Disease-Causing Gene Variant in Patient-Derived Cells and Animal Models RICHMOND, Calif., Nov.
Scientists have described a way to convert human skin cells directly into a specific type of brain cell affected by Huntington’s disease, an ultimately fatal neurodegenerative disorder.
-- Enrollment in Huntington's Trial Suspended Pending Further Assessment of Preclinical Data -- SEATTLE, Oct.
Woody Guthrie Center to house artist Phil Ochs' work TULSA, Okla., Sept.
"Rusty's Story" is an FBR Media documentary about one family's harrowing journey with Huntington's disease and medicine's decades-long search for a cure. WASHINGTON, Aug.
Researchers believe they have learned how mutations in the gene that causes Huntington’s disease kill brain cells, a finding that could open new opportunities for treating the fatal disorder.
Lack of Disease-Modifying Therapies is Expected to Remain a Critical Unmet Need and Provides Ample Opportunity for Developers, According to Findings from Decision Resources Group BURLINGTON,
Research presented by Dr. Lynn Raymond, from the University of British Columbia, shows that blocking a specific class of glutamate receptors, called extrasynaptic NMDA receptors, can improve motor learning and coordination, and prevent cell death in animal models of Huntington disease.
WASHINGTON, May 20, 2014 /PRNewswire/ -- Young people from Baltimore to Richmond impacted by Huntington Disease -- a hereditary, progressively degenerative brain disorder that leads to death
RICHMOND, Calif., May 14, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.